Symbols / DOCS Stock $23.39 -11.57% Doximity, Inc.
DOCS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-05-11 | main | Wells Fargo | Overweight → Overweight | $32 |
| 2026-04-20 | down | Truist Securities | Buy → Hold | $29 |
| 2026-04-16 | main | B of A Securities | Buy → Buy | $47 |
| 2026-04-13 | main | Keybanc | Overweight → Overweight | $30 |
| 2026-04-09 | main | Goldman Sachs | Neutral → Neutral | $28 |
| 2026-04-08 | down | Evercore ISI Group | Outperform → In-Line | $25 |
| 2026-03-18 | init | Freedom Capital Markets | — → Buy | $31 |
| 2026-03-09 | reit | RBC Capital | Outperform → Outperform | $44 |
| 2026-02-20 | main | JP Morgan | Neutral → Neutral | $33 |
| 2026-02-20 | main | Piper Sandler | Overweight → Overweight | $42 |
| 2026-02-11 | main | Barclays | Overweight → Overweight | $38 |
| 2026-02-10 | main | Mizuho | Neutral → Neutral | $34 |
| 2026-02-09 | up | Canaccord Genuity | Hold → Buy | $34 |
| 2026-02-09 | main | Goldman Sachs | Neutral → Neutral | $34 |
| 2026-02-06 | main | Wells Fargo | Overweight → Overweight | $45 |
| 2026-02-06 | up | JP Morgan | Underweight → Neutral | $40 |
| 2026-02-06 | main | Morgan Stanley | Overweight → Overweight | $49 |
| 2026-02-06 | main | Piper Sandler | Overweight → Overweight | $40 |
| 2026-02-06 | main | Truist Securities | Buy → Buy | $37 |
| 2026-02-06 | main | Needham | Buy → Buy | $55 |
- Doximity Stock Dives On Q4 Earnings, Weak Outlook - Yahoo Finance Wed, 13 May 2026 20
- AI that writes doctor notes: Doximity and Aledade join forces - Stock Titan Wed, 13 May 2026 20
- After-hours movers: CSCO, HPE, DOCS, STUB, STAA, GO - Investing.com Wed, 13 May 2026 20
- Doximity Stock Plummets. A Weak Revenue Outlook Is Weighing on the Telehealth Company. - Barron's Wed, 13 May 2026 21
- Doximity Stock Plunges as Weak 2027 Forecast Drowns Out AI Push - TechStock² Wed, 13 May 2026 22
- 800,000 doctors now use Doximity tools, half tap its clinical AI - Stock Titan Wed, 13 May 2026 20
- Earnings Flash (DOCS) Doximity, Inc. Posts Q4 Adjusted EPS $0.26 per Share, vs. FactSet Est of $0.28 - marketscreener.com Wed, 13 May 2026 20
- Doximity, Inc. (DOCS) Stock Analysis: Exploring a 45% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews Mon, 11 May 2026 09
- Why Doximity Stock Is Sinking Ahead of Earnings - TipRanks Wed, 13 May 2026 15
- Doximity (NYSE:DOCS) Posts Q1 CY2026 Sales In Line With Estimates But Stock Drops 11.1% - Yahoo Finance Australia Wed, 13 May 2026 20
- Doximity (NYSE:DOCS) Stock Rating Upgraded by Zacks Research - MarketBeat hu, 23 Apr 2026 07
- Assessing Doximity (DOCS) Valuation As Analyst Forecasts Shift Before Key Earnings Release - simplywall.st Mon, 11 May 2026 01
- Precision Trading with Doximity Inc. Class A (DOCS) Risk Zones - Stock Traders Daily ue, 12 May 2026 15
- Doximity (DOCS) Q1 Earnings: What To Expect - TradingView ue, 12 May 2026 03
- Doximity (DOCS) interim PFO exercises options and sells 2,309 shares under 10b5-1 plan - Stock Titan Wed, 13 May 2026 20
Insider Transactions
Financials
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
570.40
+19.98%
|
475.42
+13.45%
|
419.05
+21.98%
|
343.55
|
| Operating Revenue |
|
543.77
+20.82%
|
450.07
+15.48%
|
389.74
+22.06%
|
319.30
|
| Cost Of Revenue |
|
55.87
+10.27%
|
50.67
-5.27%
|
53.49
+34.44%
|
39.79
|
| Reconciled Cost Of Revenue |
|
55.87
+10.27%
|
50.67
-5.27%
|
53.49
+34.44%
|
39.79
|
| Gross Profit |
|
514.52
+21.14%
|
424.75
+16.19%
|
365.56
+20.35%
|
303.76
|
| Operating Expense |
|
284.42
+12.45%
|
252.94
+5.19%
|
240.45
+26.41%
|
190.22
|
| Research And Development |
|
93.04
+13.48%
|
81.98
+2.24%
|
80.19
+28.61%
|
62.35
|
| Selling General And Administration |
|
191.38
+11.95%
|
170.96
+6.67%
|
160.27
+25.33%
|
127.88
|
| Selling And Marketing Expense |
|
145.71
+9.45%
|
133.13
+7.78%
|
123.52
+34.08%
|
92.13
|
| General And Administrative Expense |
|
45.67
+20.73%
|
37.83
+2.94%
|
36.74
+2.79%
|
35.75
|
| Other Gand A |
|
45.67
+20.73%
|
37.83
+2.94%
|
36.74
+2.79%
|
35.75
|
| Total Expenses |
|
340.30
+12.08%
|
303.61
+3.29%
|
293.94
+27.80%
|
230.01
|
| Operating Income |
|
230.10
+33.93%
|
171.81
+37.33%
|
125.11
+10.19%
|
113.54
|
| Total Operating Income As Reported |
|
227.80
+39.01%
|
163.88
+30.99%
|
125.11
+10.19%
|
113.54
|
| EBITDA |
|
240.76
+32.23%
|
182.08
+34.48%
|
135.39
+14.18%
|
118.58
|
| Normalized EBITDA |
|
242.90
+27.56%
|
190.42
+39.52%
|
136.48
+13.92%
|
119.81
|
| Reconciled Depreciation |
|
10.66
+3.84%
|
10.27
-0.18%
|
10.28
+104.03%
|
5.04
|
| EBIT |
|
230.10
+33.93%
|
171.81
+37.33%
|
125.11
+10.19%
|
113.54
|
| Total Unusual Items |
|
-2.13
+74.39%
|
-8.34
-662.85%
|
-1.09
+11.21%
|
-1.23
|
| Total Unusual Items Excluding Goodwill |
|
-2.13
+74.39%
|
-8.34
-662.85%
|
-1.09
+11.21%
|
-1.23
|
| Special Income Charges |
|
-2.30
+70.97%
|
-7.94
|
0.00
|
0.00
|
| Restructuring And Mergern Acquisition |
|
—
|
7.94
|
0.00
|
0.00
|
| Net Income |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-27.11%
|
154.78
|
| Pretax Income |
|
263.57
+42.32%
|
185.20
+39.09%
|
133.16
+16.80%
|
114.00
|
| Net Non Operating Interest Income Expense |
|
35.85
+65.49%
|
21.66
+133.27%
|
9.29
+332.36%
|
2.15
|
| Net Interest Income |
|
35.85
+65.49%
|
21.66
+133.27%
|
9.29
+332.36%
|
2.15
|
| Interest Income Non Operating |
|
35.85
+65.49%
|
21.66
+133.27%
|
9.29
+332.36%
|
2.15
|
| Interest Income |
|
35.85
+65.49%
|
21.66
+133.27%
|
9.29
+332.36%
|
2.15
|
| Other Income Expense |
|
-2.38
+71.22%
|
-8.28
-567.96%
|
-1.24
+26.21%
|
-1.68
|
| Other Non Operating Income Expenses |
|
-0.25
-498.39%
|
0.06
+142.47%
|
-0.15
+67.41%
|
-0.45
|
| Gain On Sale Of Security |
|
0.17
+142.04%
|
-0.40
+63.22%
|
-1.09
+11.21%
|
-1.23
|
| Gain On Sale Of Business |
|
—
|
—
|
0.00
|
0.00
|
| Tax Provision |
|
40.39
+7.36%
|
37.62
+84.97%
|
20.34
+149.87%
|
-40.78
|
| Tax Rate For Calcs |
|
0.00
-24.56%
|
0.00
+32.99%
|
0.00
-27.27%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.33
+80.68%
|
-1.69
-914.54%
|
-0.17
+35.42%
|
-0.26
|
| Net Income Including Noncontrolling Interests |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-27.11%
|
154.78
|
| Net Income From Continuing Operation Net Minority Interest |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-27.11%
|
154.78
|
| Net Income From Continuing And Discontinued Operation |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-27.11%
|
154.78
|
| Net Income Continuous Operations |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-27.11%
|
154.78
|
| Normalized Income |
|
224.99
+45.88%
|
154.23
+35.59%
|
113.74
-26.97%
|
155.76
|
| Net Income Common Stockholders |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-15.34%
|
133.26
|
| Otherunder Preferred Stock Dividend |
|
—
|
0.00
|
0.00
-100.00%
|
21.53
|
| Diluted EPS |
|
1.11
+54.17%
|
0.72
+35.85%
|
0.53
-24.29%
|
0.70
|
| Basic EPS |
|
1.19
+52.56%
|
0.78
+34.48%
|
0.58
-29.27%
|
0.82
|
| Basic Average Shares |
|
186.84
-1.75%
|
190.17
-1.56%
|
193.18
+18.16%
|
163.48
|
| Diluted Average Shares |
|
201.21
-2.20%
|
205.73
-3.60%
|
213.43
+11.73%
|
191.02
|
| Diluted NI Availto Com Stockholders |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-15.34%
|
133.26
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,264.31
+17.13%
|
1,079.37
-5.06%
|
1,136.89
+14.68%
|
991.36
|
| Current Assets |
|
1,088.62
+19.24%
|
912.94
-6.41%
|
975.45
+7.89%
|
904.14
|
| Cash Cash Equivalents And Short Term Investments |
|
915.66
+20.02%
|
762.90
-9.29%
|
841.00
+5.37%
|
798.11
|
| Cash And Cash Equivalents |
|
209.61
+116.58%
|
96.78
-38.75%
|
158.03
+40.08%
|
112.81
|
| Other Short Term Investments |
|
706.05
+6.00%
|
666.12
-2.47%
|
682.97
-0.34%
|
685.30
|
| Receivables |
|
128.35
+26.67%
|
101.33
-5.34%
|
107.05
+32.04%
|
81.07
|
| Accounts Receivable |
|
128.35
+26.67%
|
101.33
-5.34%
|
107.05
+32.04%
|
81.07
|
| Gross Accounts Receivable |
|
130.29
+26.22%
|
103.22
-4.36%
|
107.93
+32.54%
|
81.43
|
| Allowance For Doubtful Accounts Receivable |
|
-1.94
-2.32%
|
-1.89
-113.42%
|
-0.89
-147.08%
|
-0.36
|
| Prepaid Assets |
|
—
|
—
|
—
|
19.44
|
| Current Deferred Assets |
|
—
|
—
|
5.12
-7.15%
|
5.51
|
| Other Current Assets |
|
44.60
-8.43%
|
48.71
+77.72%
|
27.41
+40.99%
|
19.44
|
| Total Non Current Assets |
|
175.69
+5.56%
|
166.43
+3.10%
|
161.44
+85.09%
|
87.22
|
| Net PPE |
|
22.54
-8.55%
|
24.65
-1.79%
|
25.10
+162.12%
|
9.57
|
| Gross PPE |
|
47.49
+8.60%
|
43.73
+13.07%
|
38.67
+114.31%
|
18.05
|
| Accumulated Depreciation |
|
-24.95
-30.76%
|
-19.08
-40.55%
|
-13.57
-60.27%
|
-8.47
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
37.79
+24.28%
|
30.41
+26.87%
|
23.97
+48.29%
|
16.16
|
| Construction In Progress |
|
—
|
—
|
20.41
+35.52%
|
15.06
|
| Other Properties |
|
8.89
-27.94%
|
12.33
-10.76%
|
13.82
+1171.30%
|
1.09
|
| Leases |
|
0.82
-17.74%
|
0.99
+11.71%
|
0.89
+11.56%
|
0.80
|
| Goodwill And Other Intangible Assets |
|
91.01
-4.46%
|
95.26
-4.53%
|
99.78
+271.97%
|
26.82
|
| Goodwill |
|
67.94
+0.00%
|
67.94
+0.00%
|
67.94
+259.19%
|
18.91
|
| Other Intangible Assets |
|
23.07
-15.54%
|
27.32
-14.19%
|
31.84
+302.53%
|
7.91
|
| Non Current Deferred Assets |
|
60.01
+33.16%
|
45.07
+29.11%
|
34.91
-28.11%
|
48.56
|
| Non Current Deferred Taxes Assets |
|
60.01
+33.16%
|
45.07
+29.11%
|
34.91
-28.11%
|
48.56
|
| Other Non Current Assets |
|
2.12
+45.47%
|
1.46
-11.85%
|
1.65
-26.91%
|
2.26
|
| Total Liabilities Net Minority Interest |
|
181.68
+2.08%
|
177.98
+4.22%
|
170.77
+51.44%
|
112.76
|
| Current Liabilities |
|
156.26
+6.12%
|
147.25
+5.55%
|
139.51
+25.36%
|
111.28
|
| Payables And Accrued Expenses |
|
27.70
-11.17%
|
31.18
+51.40%
|
20.60
-1.21%
|
20.85
|
| Payables |
|
2.71
-83.33%
|
16.27
+486.13%
|
2.78
+122.44%
|
1.25
|
| Accounts Payable |
|
1.36
-39.81%
|
2.25
+77.12%
|
1.27
+174.73%
|
0.46
|
| Current Accrued Expenses |
|
24.99
+67.56%
|
14.91
-16.32%
|
17.82
-9.09%
|
19.60
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.59
+18.35%
|
0.50
-15.79%
|
0.59
-5.15%
|
0.62
|
| Total Tax Payable |
|
1.36
-90.32%
|
14.02
+832.05%
|
1.50
+91.59%
|
0.79
|
| Current Debt And Capital Lease Obligation |
|
2.21
+2.89%
|
2.15
+22.66%
|
1.75
+172.90%
|
0.64
|
| Current Capital Lease Obligation |
|
2.21
+2.89%
|
2.15
+22.66%
|
1.75
+172.90%
|
0.64
|
| Current Deferred Liabilities |
|
114.28
+15.27%
|
99.14
-5.79%
|
105.24
+23.95%
|
84.91
|
| Current Deferred Revenue |
|
114.28
+15.27%
|
99.14
-5.79%
|
105.24
+23.95%
|
84.91
|
| Other Current Liabilities |
|
11.47
-19.63%
|
14.28
+25.99%
|
11.33
+165.82%
|
4.26
|
| Total Non Current Liabilities Net Minority Interest |
|
25.43
-17.25%
|
30.73
-1.72%
|
31.27
+2011.07%
|
1.48
|
| Long Term Debt And Capital Lease Obligation |
|
10.19
-17.84%
|
12.40
-10.72%
|
13.88
+3006.26%
|
0.45
|
| Long Term Capital Lease Obligation |
|
10.19
-17.84%
|
12.40
-10.72%
|
13.88
+3006.26%
|
0.45
|
| Non Current Deferred Liabilities |
|
0.28
+32.70%
|
0.21
+6.57%
|
0.20
+153.85%
|
0.08
|
| Non Current Deferred Revenue |
|
0.28
+32.70%
|
0.21
+6.57%
|
0.20
+153.85%
|
0.08
|
| Other Non Current Liabilities |
|
14.96
-17.42%
|
18.12
+5.45%
|
17.18
+1697.28%
|
0.96
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
0.00
|
| Stockholders Equity |
|
1,082.62
+20.11%
|
901.40
-6.70%
|
966.12
+9.96%
|
878.59
|
| Common Stock Equity |
|
1,082.62
+20.11%
|
901.40
-6.70%
|
966.12
+9.96%
|
878.59
|
| Capital Stock |
|
0.19
+1.07%
|
0.19
-3.61%
|
0.19
+1.04%
|
0.19
|
| Common Stock |
|
0.19
+1.07%
|
0.19
-3.61%
|
0.19
+1.04%
|
0.19
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
188.88
+1.24%
|
186.56
-3.80%
|
193.94
+0.80%
|
192.40
|
| Ordinary Shares Number |
|
188.88
+1.24%
|
186.56
-3.80%
|
193.94
+0.80%
|
192.40
|
| Additional Paid In Capital |
|
894.23
+8.54%
|
823.88
+8.10%
|
762.15
+8.48%
|
702.59
|
| Retained Earnings |
|
186.89
+133.64%
|
79.99
-63.28%
|
217.85
+14.00%
|
191.11
|
| Gains Losses Not Affecting Retained Earnings |
|
1.32
+149.66%
|
-2.66
+81.08%
|
-14.08
+7.92%
|
-15.29
|
| Other Equity Adjustments |
|
1.32
+149.66%
|
-2.66
+81.08%
|
-14.08
+7.92%
|
-15.29
|
| Total Equity Gross Minority Interest |
|
1,082.62
+20.11%
|
901.40
-6.70%
|
966.12
+9.96%
|
878.59
|
| Total Capitalization |
|
1,082.62
+20.11%
|
901.40
-6.70%
|
966.12
+9.96%
|
878.59
|
| Working Capital |
|
932.36
+21.77%
|
765.69
-8.40%
|
835.95
+5.43%
|
792.86
|
| Invested Capital |
|
1,082.62
+20.11%
|
901.40
-6.70%
|
966.12
+9.96%
|
878.59
|
| Total Debt |
|
12.40
-14.78%
|
14.55
-6.98%
|
15.64
+1335.90%
|
1.09
|
| Capital Lease Obligations |
|
12.40
-14.78%
|
14.55
-6.98%
|
15.64
+1335.90%
|
1.09
|
| Net Tangible Assets |
|
991.61
+23.01%
|
806.14
-6.95%
|
866.34
+1.71%
|
851.77
|
| Tangible Book Value |
|
991.61
+23.01%
|
806.14
-6.95%
|
866.34
+1.71%
|
851.77
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
273.26
+48.44%
|
184.10
+2.50%
|
179.60
+41.89%
|
126.58
|
| Cash Flow From Continuing Operating Activities |
|
273.26
+48.44%
|
184.10
+2.50%
|
179.60
+41.89%
|
126.58
|
| Net Income From Continuing Operations |
|
223.19
+51.23%
|
147.58
+30.81%
|
112.82
-27.11%
|
154.78
|
| Depreciation Amortization Depletion |
|
10.66
+3.84%
|
10.27
-0.18%
|
10.28
+104.03%
|
5.04
|
| Depreciation And Amortization |
|
10.66
+3.84%
|
10.27
-0.18%
|
10.28
+104.03%
|
5.04
|
| Other Non Cash Items |
|
12.07
-10.74%
|
13.53
+1.27%
|
13.36
+17.97%
|
11.32
|
| Stock Based Compensation |
|
72.39
+41.72%
|
51.08
+6.78%
|
47.83
+52.13%
|
31.44
|
| Asset Impairment Charge |
|
2.30
|
0.00
|
0.00
|
—
|
| Deferred Tax |
|
-11.59
-34.90%
|
-8.59
-164.97%
|
13.23
+132.07%
|
-41.25
|
| Deferred Income Tax |
|
-11.59
-34.90%
|
-8.59
-164.97%
|
13.23
+132.07%
|
-41.25
|
| Operating Gains Losses |
|
—
|
0.40
-63.22%
|
1.09
-11.21%
|
1.23
|
| Gain Loss On Investment Securities |
|
—
|
0.40
-63.22%
|
1.09
-11.21%
|
1.23
|
| Change In Working Capital |
|
-24.10
+1.74%
|
-24.52
-16.60%
|
-21.03
+47.85%
|
-40.33
|
| Change In Receivables |
|
-27.21
-781.34%
|
3.99
+115.22%
|
-26.24
+15.39%
|
-31.02
|
| Changes In Account Receivables |
|
-27.21
-781.34%
|
3.99
+115.22%
|
-26.24
+15.39%
|
-31.02
|
| Change In Prepaid Assets |
|
2.76
+113.48%
|
-20.48
-494.05%
|
-3.45
+62.06%
|
-9.09
|
| Change In Payables And Accrued Expense |
|
-0.66
-107.96%
|
8.33
+4372.82%
|
-0.20
-102.25%
|
8.66
|
| Change In Payable |
|
-0.66
-107.96%
|
8.33
+4372.82%
|
-0.20
-102.25%
|
8.66
|
| Change In Account Payable |
|
-0.66
-107.96%
|
8.33
+4372.82%
|
-0.20
-102.25%
|
8.66
|
| Change In Other Working Capital |
|
3.16
+121.51%
|
-14.69
-262.03%
|
9.06
+216.50%
|
-7.78
|
| Change In Other Current Liabilities |
|
-2.15
-28.07%
|
-1.68
-687.79%
|
-0.21
+80.76%
|
-1.11
|
| Investing Cash Flow |
|
-29.30
-193.95%
|
31.19
+152.04%
|
-59.92
+90.65%
|
-640.57
|
| Cash Flow From Continuing Investing Activities |
|
-29.30
-193.95%
|
31.19
+152.04%
|
-59.92
+90.65%
|
-640.57
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.15
+91.36%
|
-1.70
+11.04%
|
-1.91
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.15
+91.36%
|
-1.70
+11.04%
|
-1.91
|
| Capital Expenditure |
|
-6.53
-12.48%
|
-5.80
+6.19%
|
-6.18
-8.55%
|
-5.70
|
| Net Investment Purchase And Sale |
|
-22.77
-161.57%
|
36.99
+15575.73%
|
-0.24
+99.96%
|
-635.47
|
| Purchase Of Investment |
|
-675.56
-42.86%
|
-472.87
-148.15%
|
-190.56
+85.53%
|
-1,317.19
|
| Sale Of Investment |
|
652.78
+28.03%
|
509.85
+167.89%
|
190.32
-72.08%
|
681.72
|
| Net Business Purchase And Sale |
|
0.00
|
0.00
+100.00%
|
-53.50
|
0.00
|
| Purchase Of Business |
|
0.00
|
0.00
+100.00%
|
-53.50
|
0.00
|
| Gain Loss On Sale Of Business |
|
—
|
—
|
0.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-6.53
-15.41%
|
-5.65
-26.12%
|
-4.48
-18.44%
|
-3.79
|
| Purchase Of Intangibles |
|
-6.53
-15.41%
|
-5.65
-26.12%
|
-4.48
-18.44%
|
-3.79
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
0.59
|
| Financing Cash Flow |
|
-131.14
+52.58%
|
-276.52
-271.37%
|
-74.46
-113.29%
|
560.41
|
| Cash Flow From Continuing Financing Activities |
|
-131.14
+52.58%
|
-276.52
-271.37%
|
-74.46
-113.29%
|
560.41
|
| Net Common Stock Issuance |
|
-120.29
+57.15%
|
-280.72
-229.00%
|
-85.32
-115.48%
|
551.21
|
| Common Stock Payments |
|
-120.29
+57.15%
|
-280.72
-229.00%
|
-85.32
-3062.49%
|
-2.70
|
| Repurchase Of Capital Stock |
|
-120.29
+57.15%
|
-280.72
-229.00%
|
-85.32
-3062.49%
|
-2.70
|
| Proceeds From Stock Option Exercised |
|
23.30
+42.62%
|
16.34
+11.26%
|
14.69
+4.84%
|
14.01
|
| Net Other Financing Charges |
|
-34.15
-181.13%
|
-12.15
-217.79%
|
-3.82
+20.36%
|
-4.80
|
| Changes In Cash |
|
112.83
+284.23%
|
-61.24
-235.44%
|
45.22
-2.58%
|
46.42
|
| Beginning Cash Position |
|
96.78
-38.75%
|
158.03
+40.08%
|
112.81
+69.91%
|
66.39
|
| End Cash Position |
|
209.61
+116.58%
|
96.78
-38.75%
|
158.03
+40.08%
|
112.81
|
| Free Cash Flow |
|
266.74
+49.61%
|
178.29
+2.81%
|
173.42
+43.47%
|
120.88
|
| Income Tax Paid Supplemental Data |
|
55.65
+8.54%
|
51.27
+880.19%
|
5.23
+2439.32%
|
0.21
|
| Amortization Of Securities |
|
-11.65
-122.51%
|
-5.24
-268.15%
|
3.12
-28.09%
|
4.33
|
| Common Stock Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
553.90
|
| Issuance Of Capital Stock |
|
—
|
0.00
|
0.00
-100.00%
|
553.90
|
| Sale Of Business |
|
—
|
—
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-05-13 View
- 8-K2026-05-13 View
- 42026-05-08 View
- 8-K2026-04-17 View
- 42026-04-14 View
- 42026-03-12 View
- 42026-03-12 View
- 42026-03-05 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 10-Q2026-02-05 View
- 8-K2026-02-05 View
- 42026-02-04 View
- 42026-01-06 View
- 8-K2025-12-30 View
- 42025-12-03 View
- 42025-11-24 View
- 42025-11-18 View
- 42025-11-18 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|